Denali Therapeutics Inc. (NASDAQ:DNLI) showed up in the 13F filings of 246 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 425,575 | 3.46% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 1,064,972 | 8.88% | $0.00 |
| T. Rowe Price Investment Management, Inc. | 31 Dec, 2025 | 0 | 2,861,559 | 50.75% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -285,525 | -41.21% | $0.00 |
| BAILLIE GIFFORD & CO | 31 Dec, 2025 | 0 | 719,304 | 6.21% | $0.00 |
| Holocene Advisors, LP | 31 Dec, 2025 | 0 | 17,022 | 0.54% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 1,447 | 133.61% | $0.00 |
| Temasek Holdings (Private) Ltd | 31 Dec, 2025 | 0 | 1,657,142 | 30.94% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | 392,351 | 19.50% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 799,110 | 14.62% | $0.00 |
| Aberdeen Group plc | 31 Dec, 2025 | 0 | 919,381 | 82.56% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | -243,105 | -3.83% | $0.00 |
| Lynx1 Capital Management LP | 31 Dec, 2025 | 0 | 1,477,063 | 564.44% | $0.00 |
| NORGES BANK | 31 Dec, 2025 | 0 | 5,119,622 | 0.00% | $0.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 0 | -819,535 | -32.53% | $0.00 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 31 Dec, 2025 | 0 | -481,311 | -8.81% | $0.00 |
| Siren, L.L.C. | 31 Dec, 2025 | 0 | 575,000 | 69.99% | $0.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 0 | 1,672,098 | 77.28% | $0.00 |
| Pictet Asset Management Holding SA | 31 Dec, 2025 | 0 | 829,946 | 166.27% | $0.00 |
| BAKER BROS. ADVISORS LP | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |